pillbase.ru

Takhzyro

Active substance: lanadelumab

lanadelumab

Centralised EU authorisationActive

Marketing holder: Takeda Pharmaceuticals International AG Ireland Branch

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • TAKHZYRO
    SOLUTION · LANADELUMAB 150 mg/mL
    47783-645
    Takeda Pharmaceuticals America, Inc.
  • TAKHZYRO
    SOLUTION · LANADELUMAB 300 mg/2mL
    47783-646
    Takeda Pharmaceuticals America, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-bc13-7d3b-9f82-62c53490a6ba,01a12095-de1c-74e3-a55d-33e295649b67;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004806
Registration status
Active
ATC code
B06AC05
Sources
  • product · EMA · EMEA/H/C/004806 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004806 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004806 · Verified 2026-10-09